Low-Level Viraemia Dominates Detectable Viral Loads in Cameroon Cohort Study
A pilot cohort study in Cameroon found persistent low-level viraemia accounted for approximately three-quarters of detectable viral loads in adults ...
A pilot cohort study in Cameroon found persistent low-level viraemia accounted for approximately three-quarters of detectable viral loads in adults ...
A 144-week Zambian trial found that people living with HIV receiving tenofovir, lamivudine, and dolutegravir experienced significantly higher odds of ...
A retrospective cohort study of 420 HIV-positive pregnant women in Nigeria found no significant difference in adverse birth outcomes between ...
A cross-sectional study of 496 HIV-positive pregnant and lactating women in Addis Ababa found that 11.3 percent experienced viral non-suppression ...
A multicenter cohort study of 1,466 adults in Henan Province found that simplified two-drug antiretroviral regimens maintained stable viral suppression, ...
A six-year retrospective cohort study of 1,214 newly diagnosed individuals in central Guangxi identified a 6.01 percent pretreatment HIV-1 drug ...
A descriptive analysis of routine electronic medical records from Mildmay Uganda shows a marked clinical transition from acute opportunistic infections ...
A cross-sectional survey of 308 people living with HIV at Bule Hora University Teaching Hospital in Ethiopia found that 76.0 ...
A human cell-based in vitro study reports that highly protein-bound antivirals such as dolutegravir and efavirenz show reduced permeability across ...
A systematic review and meta-analysis finds substantial diabetes and hypertension burden among adults on dolutegravir-based HIV therapy in Sub-Saharan Africa, ...
A cross-sectional study of 318 adults with HIV at a Vietnamese health center in 2024 found that 98.69 percent of ...
A six-year Japanese post-marketing study found sustained HIV suppression and stable CD4+ T-cell counts in a small cohort that switched ...
A randomized trial combining in situ viral imaging and mass spectrometry shows that first-line dolutegravir/lamivudine therapy penetrates lymph node tissue ...
Dolutegravir, one of the most widely prescribed antiretroviral drugs in the world, may interfere with the developing heart and blood ...
A 48-week prospective cohort study finds that switching men with HIV off tenofovir disoproxil fumarate to TAF-based or tenofovir-free regimens, ...
A combined animal and clinical study finds that the standard TLD antiretroviral regimen disrupts estrous cycling, damages ovarian tissue, and ...
A prospective cohort of 396 newly diagnosed patients at a Casablanca tertiary care center reveals widespread late presentation, heavy tuberculosis ...
A cross-sectional study of 54 HIV-positive adults with type 2 diabetes at Uganda's Lira Regional Referral Hospital finds that glycemic ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.